Sales of TNF-a inhibitor for rheumatoid arthritis increased by 21% compared to the previous year

Published: 2014-09-11 14:51:35

Updated: 2014-09-11 14:51:35

On September 4, according to the sales analysis of recently released TNF-a inhibitor and new drug for rheumatoid arthritis treatment in the second half of the year, its sales increased by 21% compared to the previous year.

The growth was driven by Humira (Abbvie) and Remicade (Janssen) which recorded growth rate of 16.9% (10.9 billion won) and 11.3% (7.6 billion won), respectively.

Humira is ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.